Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;68(6):1329-1334.
doi: 10.1007/s00125-025-06399-2. Epub 2025 Mar 7.

Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes

Affiliations

Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes

Amy T Tsoi et al. Diabetologia. 2025 Jun.

Abstract

Aims/hypothesis: Diabetic peripheral neuropathy is a debilitating microvascular complication of diabetes mellitus, with limited disease-modifying therapies to date. This study aimed to assess the effect of metformin on the corneal sub-basal nerve plexus as a peripheral neuropathy outcome measure in people with type 2 diabetes.

Methods: A cohort of 36 participants with type 2 diabetes receiving metformin therapy were recruited and underwent clinical assessment, corneal confocal microscopy and nerve conduction studies. Concurrently, 36 participants with type 2 diabetes not receiving metformin therapy were selected as disease controls and matched to participants on metformin therapy for age, sex, diabetes duration, BMI, eGFR, HbA1c, use of other oral glucose-lowering agents and therapies used for the treatment of the metabolic syndrome. Additionally, 25 healthy control participants were assessed and matched for age and sex. Medical record data over the previous 20 years were analysed for prior and current metformin use in all participants with type 2 diabetes.

Results: Participants receiving metformin therapy had higher corneal nerve fibre density (p=0.020), corneal nerve fibre length (p=0.020) and corneal fractal dimension (p=0.003) compared with those not receiving metformin therapy. The inferior whorl dendritic cell density was significantly lower in the metformin group compared with the non-metformin group (p=0.043).

Conclusions/interpretation: Metformin treatment is associated with superior corneal nerve parameters and neuroimmune tone in the corneal sub-basal nerve plexus. This study provides further evidence that metformin may be neuroprotective in diabetic peripheral neuropathy.

Keywords: Corneal nerve injury; Diabetic peripheral neuropathy; In vivo corneal confocal microscopy; Metformin.

PubMed Disclaimer

Conflict of interest statement

Acknowledgements: The authors gratefully acknowledge the team at the Prince of Wales Diabetes Centre for their support in participant recruitment. We would like to thank D. Cornblath and Johns Hopkins University for providing the Total Neuropathy Score to A. Krishnan. Data availability: The data that support the findings of this study are not publicly available due to institutional ethics review board restrictions (Human Research Ethics Committee of the South Eastern Sydney Local Health District HREC Ref. 14/012). Funding: Open Access funding enabled and organized by CAUL and its Member Institutions. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Authors’ relationships and activities: The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work. Contribution statement: ATT was involved in recruitment, data collection, data interpretation and manuscript composition. JS was involved in data collection and data analysis. SST was involved in data collection. TI was involved in data interpretation. AMP and K-LM were the treating clinicians of recruited participants and were involved in patient recruitment and data collection. MM, RD and AVK supervised data collection, data interpretation and data analysis. AVK was involved in study design, data interpretation, manuscript composition and is the guarantor of this work. As such AVK had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to the drafting of the article or critically reviewed it for important intellectual content. All authors approved the final version of the manuscript.

Figures

Fig. 1
Fig. 1
Group comparison of corneal nerve parameters for metformin, non-metformin and control groups. Values are expressed as mean ± SE for (a) corneal nerve fibre length (CNFL), (b) corneal fractal dimension (CFractal), (c) corneal nerve branch density (CNBD) and (d) corneal nerve fibre density (CNFD). Values presented as a box and whiskers plot for (e) central corneal intraepithelial lymphocytes, (f) central corneal dendritic cells, (g) inferior whorl intraepithelial lymphocytes, and (h) inferior whorl dendritic cells. The central line represents the median and the upper and lower limits of the box represent the 25th and 75th percentiles. The whiskers represent the 10th and 90th percentiles. *p<0.05, **p<0.01

References

    1. Pop-Busui R, Boulton AJ, Feldman EL et al (2017) Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care 40(1):136–154. 10.2337/dc16-2042 - PMC - PubMed
    1. Buonfiglio F, Wasielica-Poslednik J, Pfeiffer N, Gericke A (2024) Diabetic keratopathy: redox signaling pathways and therapeutic prospects. Antioxidants (Basel) 13(1):120. 10.3390/antiox13010120 - PMC - PubMed
    1. Perkins BA, Lovblom LE, Bril V et al (2018) Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia 61(8):1856–1861. 10.1007/s00125-018-4653-8 - PMC - PubMed
    1. Kim SH, Park TS, Jin HY (2020) Metformin preserves peripheral nerve damage with comparable effects to alpha lipoic acid in streptozotocin/high-fat diet induced diabetic rats. Diabetes Metab J 44(6):842–853. 10.4093/dmj.2019.0190 - PMC - PubMed
    1. Vagenas D, Pritchard N, Edwards K et al (2012) Optimal image sample size for corneal nerve morphometry. Optom Vis Sci 89(5):812–817. 10.1097/OPX.0b013e31824ee8c9 - PubMed